Samsung Electronics Co., Ltd.

Korea Advanced Institute of Science and Technology

Hyo Seon Lee

Sang Yeul Han

Kyung Eun Kim

Hyung-Chan Kim

Kwang Hoon Lee

Seok Kyun Kim

Seung Ja Oh

Yong In Kim

Yoon Sook Lee

Chung Ho Kim

Seung Hyun Lee

Su Jin Kim

Sunghyun Kim

Jae Young Choi

Chan Kim

Ji Min Lee

Kyung Ah Kim

Gou Young Koh

Yun Ju Jeong

Saet Byoul Lee

Kwang-Hoon Lee

Yun Jeong Song

Jae Hyun Choi

An anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes with a Tie2 receptor and Ang2, and related methods and compositions.

Anti-ANG2 antibody

An anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes with a Tie2 receptor through Ang2, and methods of using the same.

Humanized or affinity-matured anti ang-2 antibody and uses thereof

An Ang2 specific antibody, a method of inhibiting angiogenesis or a method of treating a disease related to the activation and/or overproduction of Ang2 using the antibody, and a composition for diagnosing a disease related to the activation and/or overproduction of Ang2 including the antibody.

Angiopoietin-2 specific antibodies and uses thereof

Humanized or affinity-matured anti Ang-2 antibody and uses thereof

Provided is a method of combination therapy for prevention or treatment of c-Met-induced or angiogenesis factor-induced diseases including co-administering an angiogenesis inhibitor and an anti-c-Met antibody or an antigen-binding fragment thereof to a patient.

Method of combination therapy for prevention or treatment of c-Met or angiogenesis factor induced diseases

A method for the prevention and/or treatment of a disease accompanied by vascular leakage and/or vascular inflammation comprising administering an anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and forms a complex with a Tie2 receptor and Ang2.

Method of blocking vascular leakage using an anti-ANG2 antibody

Anti-Ang2 antibody

An Ang2 specific antibody, a method of preventing and/or treating a disease related to the activation and/or overproduction (overexpression) of Ang2 by administering the antibody to a subject, and a method of screening a candidate substance for diagnosing, preventing, or treating a disease related to activation or overproduction of Ang2.

Antibody specifically binding to ANG2 and use thereof

Provided are an anti-Ang-2 antibody or antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang-2), related compositions and pharmaceutical compositions, and methods for using such compositions and pharmaceutical compositions.

Ang-2 specific antibodies and uses thereof

A method of preventing or treating cancer using an anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes to a Tie2 receptor while bound with Ang2.

Use of an anti-Ang2 antibody

There are provided an angiopoietin-2 (Ang2) derived peptides, polypeptides, and peptide complexes, and a method for inhibition of binding between Ang2 and integrin and prevention and/or treatment of a disease caused by the activation of Ang2 or the binding between Ang2 and integrin using the peptide, polypeptides, and peptide complexes.

Peptide for inhibition of binding between angiopoietin-2 and integrin and use thereof

An apparatus for interpolating pixels using correlated dual sample-hold processing for detecting and removing dark current occurring during the feed through period to thereby improve the resolution of a 3-panel type video camera includes first and second composite delay elements for selectively delaying respective ones of signals corresponding to R, G and B channels to permit selected delay of a pair of the signals by 1/2 pitch delays of 1/3 pitch delays during interlacing for interpolating pixels. A method for signal processing using selected pitch delay values is also disclosed.

Growing community of inventors

Hwaseong-si, South Korea

Hyo Seon Lee